Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?

Lung Cancer

Volumn 81, Issue 2, 2013, Pages 302-305

  Zhang, Yan ^a   Li, Xiao Yu ^a   Tang, Yuan ^a   Xu, Yong ^a   Guo, Wen Hao ^a   Li, Yan Chu ^a   Liu, Xiao Ke ^a   Huang, Chu Ying ^a   Wang, Yong Sheng ^a   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

EGFR mutation; Neuron specific enolase; Non small cell lung cancer; Small cell lung cancer transformation

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD56 ANTIGEN; CHROMOGRANIN; CISPLATIN; ETOPOSIDE; GEFITINIB; KI 67 ANTIGEN; MEDRONIC ACID; NEURON SPECIFIC ENOLASE; NUCLEAR FACTOR I; SYNAPTOPHYSIN;

AGED; ARTICLE; BONE DESTRUCTION; BONE SCINTISCANNING; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DYSURIA; HUMAN; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOFT TISSUE METASTASIS; TACHYPHYLAXIS; UPREGULATION; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EGFR MUTATION; NEURON SPECIFIC ENOLASE; NON-SMALL CELL LUNG CANCER; SMALL CELL LUNG CANCER TRANSFORMATION;

ADENOCARCINOMA; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; PHOSPHOPYRUVATE HYDRATASE; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SMALL CELL LUNG CARCINOMA; TACHYPHYLAXIS;

EID: 84879880262     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.04.005     Document Type: Article

References (11)

1. Kris M.G., Johnson B.E., Kwiatkowski D.J., Iafrate A.J., Wistuba I.I., Aronson S.L., et al. Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: the NCI's Lung Cancer Mutation Consortium (LCMC). ASCO Meeting Abstracts 2011, 29:CRA7506.
2. D'Angelo S.P., Pietanza M.C., Johnson M.L., Riely G.J., Miller V.A., Sima C.S., et al. Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas. J Clin Oncol 2011, 29:2066-2070.
3. Sequist L.V., Waltman B.A., Dias-Santagata D., Digumarthy S., Turke A.B., Fidias P., et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 2011, 3(75):ra26.
4. Morinaga R., Okamoto I., Furuta K., Kawano Y., Sekijima M., Dote K., et al. Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation. Lung Cancer 2007, 58:411-413.
5. Zakowski M.F., Ladanyi M., Kris M.G. EGFR mutations in small-cell lung cancers in patients who have never smoked. N Engl J Med 2006, 355:213-215.
6. Popat S., Wotherspoon A., Nutting C.M., Gonzalez D., Nicholson A.G., O'Brien M. Transformation to "high grade" neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma. Lung Cancer 2013, 80(1):1-4.
7. Sun Y., Shi Y., Zhang L., Liu X., Zhou C., Wang D., et al. A randomized, double-blind phase III study of icotinib versus gefitinib in patients with advanced non-small cell lung cancer (NSCLC) previously treated with chemotherapy (ICOGEN). ASCO Meeting Abstracts 2011, 29:7522-7530.
8. van Riel S., Thunnissen E., Heideman D., Smit E.F., Biesma B. A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation. Ann Oncol 2012, 23:3188-3189.
9. Fukui T., Tsuta K., Furuta K., Watanabe S., Asamura H., Ohe Y., et al. Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung. Cancer Sci 2007, 98:1714-1719.
10. Toyokawa G., Taguchi K., Ohba T., Morodomi Y., Takenaka T., Hirai F., et al. First case of combined small-cell lung cancer with adenocarcinoma harboring EML4-ALK fusion and an exon 19 EGFR mutation in each histological component. J Thorac Oncol 2012, 7:e39-e41.
11. Tatematsu A., Shimizu J., Murakami Y., Horio Y., Nakamura S., Hida T., et al. Epidermal growth factor receptor mutations in small cell lung cancer. Clin Cancer Res 2008, 14:6092-6096.